Medicare open enrollment begins Thursday and runs until Dec. 7, letting people choose between traditional Medicare, Medicare Advantage and prescription drug plans, with 2027 changes taking effect Jan. 1. The Part D out-of-pocket cap will rise to $2,400 from $2,100, the standard deductible will increase from $615 to $700, and a temporary Part D premium subsidy will end. New negotiated prices will apply to 15 drugs, including Ozempic, Rybelsus and Wegovy, and CMS projects a $685 million effect on prescription drug coverage in 2027. Some Medicare Advantage plans are leaving areas or scaling back benefits, while Social Security recipients will receive a 3.6% cost-of-living increase, and the administration plans one-time $90 payments for more than 20 million Part B enrollees.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on ksla.com ↗
Related news
- Medicare Open Enrollment Begins: What to Expect for 2027
Medicare open enrollment began Thursday and runs through Dec. 7, letting enrollees choose between traditional Medicare, Medicare Advantage plans, and prescription drug plans for changes effective Jan. 1, 2027. Key changes include a rise in the Part D out-of-pocket cap to $2,400 from $2,100, a standard deductible increase from $615 to $700, and the early end of a temporary federal Part D premium subsidy. New negotiated prices for 15 drugs, including Ozempic, Wegovy and Rybelsus, take effect, and CMS expects this to lower prescription drug coverage costs by $685 million in 2027. Some Medicare Advantage plans are exiting areas and cutting benefits such as dental coverage, which an advocate says could disrupt coverage for some enrollees. Separately, Social Security recipients will get a 3.6% cost-of-living increase in 2027, and Trump has announced one-time $90 payments in October for more than 20 million Medicare enrollees.
- Medicare Open Enrollment Begins , 2027 Plan Changes Announced
Medicare open enrollment runs from October 15 to December 7 for coverage starting January 1, 2027, affecting more than 70 million enrollees facing drug coverage and cost changes. The Part D out-of-pocket cap rises to $2,400 from $2,100, and the standard deductible increases from $615 to $700. A temporary Part D premium subsidy will end early at year's end, though CMS projects only modest increases for most people. Medicare-negotiated prices for 15 drugs, including Ozempic and Wegovy, take effect January 1. Separately, President Trump announced one-time payments of $90 in October to more than 20 million Part B enrollees, excluding roughly 35 million Medicare Advantage enrollees.
- Medicare Open Enrollment Begins , 2027 Plan Changes Announced
Medicare open enrollment starts Thursday, October 15, and runs until December 7 for coverage beginning January 1, 2027, affecting more than 70 million enrollees. The Social Security Administration set a 3.6% cost-of-living increase for 2027, about $75 more per month for nearly 72 million beneficiaries, while the Part D out-of-pocket cap rises from $2,100 to $2,400 and the standard deductible from $615 to $700. A temporary Part D premium subsidy will end early at year’s end, though CMS projects only modest price increases for most people. Medicare-negotiated prices for 15 drugs, including Ozempic, Wegovy and Trelegy Ellipta, take effect January 1. The Trump administration also plans one-time $90 payments in October to more than 20 million enrollees to help with Part B premiums, costing about $2 billion.
- Medicare Open Enrollment Begins , 2027 Plan Changes Announced
Medicare open enrollment begins October 15 and runs until December 7 for coverage starting January 1, 2027, affecting more than 70 million enrollees facing changes to prescription drug coverage and costs. The Social Security Administration will raise cost-of-living adjustments by 3.6% in 2027, about $75 more per month for nearly 72 million beneficiaries. The Part D out-of-pocket cap rises from $2,100 in 2026 to $2,400 in 2027, the standard deductible increases from $615 to $700, and a temporary Part D premium subsidy ends early at year's end. Medicare-negotiated prices for 15 drugs, including Ozempic, Wegovy and Rybelsus, take effect January 1. President Donald Trump also announced one-time payments of $90 in October to more than 20 million enrollees for Part B premiums, costing about $2 billion and excluding roughly 35 million Medicare Advantage enrollees.
- Medicare Open Enrollment Begins, 2027 Plan Changes Announced
Medicare open enrollment runs from October 15 to December 7, letting more than 70 million enrollees choose traditional Medicare, Medicare Advantage plans or prescription drug plans for coverage starting January 1, 2027. Social Security benefits will rise 3.6% in 2027, about $75 more per month for nearly 72 million recipients, while the annual out-of-pocket cap for Part D drugs goes from $2,100 to $2,400 and the standard deductible from $615 to $700. The temporary Part D premium subsidy will end early at year's end, though CMS projects only modest price increases for most people. Negotiated Medicare prices for 15 drugs, including Ozempic and Wegovy, take effect January 1, and President Trump announced one-time $90 payments for more than 20 million Part B enrollees, costing about $2 billion and excluding roughly 35 million Medicare Advantage enrollees.
- Medicare Open Enrollment Begins , 2027 Plan Changes Announced
Medicare open enrollment runs from Thursday (October 15) to December 7, letting more than 70 million enrollees choose coverage effective January 1, 2027. The Social Security cost-of-living adjustment rises 3.6% in 2027, about $75 more per month for nearly 72 million beneficiaries. The Part D out-of-pocket cap rises from $2,100 to $2,400 and the standard deductible from $615 to $700, while a temporary Part D premium subsidy ends early at year's end. Medicare-negotiated prices for 15 drugs, including Ozempic, Wegovy and Rybelsus, take effect January 1, and CMS estimates the change will lower prescription drug coverage by $685 million in 2027. President Trump announced one-time $90 payments in October for more than 20 million enrollees to help with Part B premiums, costing about $2 billion, but not for roughly 35 million Medicare Advantage enrollees or other groups.
Related markets
Latest news
- Bitcoin ETFs just saw their biggest day in a month thanks entirely to BlackRock
U.S. spot bitcoin ETFs took in $526.6 million on Monday, the largest daily net inflow in nearly a month, driven entirely by BlackRock's iShares Bitcoin Trust (IBIT), which pulled in $665.2 million, its biggest daily inflow since Oct. 7 last year, according to SoSoValue data. Fidelity's FBTC lost $83.6 million and Grayscale's GBTC shed $54.9 million, while the remaining funds recorded no net flows. The inflow more than erased last week's $228.5 million of withdrawals, but funds remain about $90.5 million in net outflows for October, according to CoinDesk calculations. Ether funds moved the opposite way, losing $103.3 million in their fourth consecutive session of outflows, with BlackRock's ETHA accounting for $95.4 million of that.
- A Big4 bank cut deposit rates in the morning, then raised them again in the afternoon
VietinBank cut its deposit rates for terms of 6 months and longer on the morning of Oct. 20, then restored them to pre-adjustment levels by the afternoon. Its afternoon rate board showed 3.5% per year for 6 to under 12 months, 5.9% for 12 to under 24 months and 6% for 24 months and longer, versus 3%, 5.4% and 5.5% in the morning. Rates for terms under 6 months stayed unchanged, including 2.1% for 1 to under 3 months and 2.4% for 3 to under 6 months. The move came as banks followed the State Bank of Vietnam's guidance to cut deposit rates by at least 0.5 percentage points for terms of 6 months and longer, and Vietcombank and Agribank were among those reducing rates.
- IVV vs. SPY: Which S&P 500 ETF Is the Better Buy for Long-Term Investors?
The article compares two ETFs that track the S&P 500, iShares Core S&P 500 ETF (IVV) and State Street SPDR S&P 500 ETF (SPY), which have nearly identical holdings. The main difference is the expense ratio: IVV charges 0.03% a year, one-third of SPY's 0.09%, and its distribution yield is about 1.1% versus 1% for SPY. SPY's high liquidity remains valuable for active traders. The article concludes that IVV is the better choice for long-term investors, since lower costs can compound over time.
- Warren Buffett Is Issuing a Stark Warning About the Stock Market. Here's What History Says Comes Next.
Warren Buffett has warned that investors are taking on too much risk, likening the market to 'a church with a casino attached' and saying people have never been in a more gambling mood. The article points to the S&P 500 Shiller CAPE Ratio, which has stayed above 40 since May of this year; historically, the only other time it held above that level for months was during the dot-com bubble, when it peaked around 44 before the bear market began in March 2000. The article notes that 40 is not an automatic trigger for a downturn, and no metric can predict timing. It suggests investors focus on quality stocks with solid fundamentals and be ready to hold them for at least a few years.
- Early Uber Investor Jason Calacanis Predicts Waymo Could Buy Lucid Or Rivian — Calls Its Chinese-Car Optics ‘Really Bad’
Early Uber investor Jason Calacanis predicts Waymo will buy Lucid Group (LCID) or Rivian Automotive (RIVN), arguing that its reliance on Chinese-made Zeekr vehicles creates cost and reputational problems. He says the arrangement is technically not illegal today, but Waymo would need to pay a tariff of over 100%, and it has drawn national-security concerns on Capitol Hill. According to Semafor, Waymo aims to grow its fleet from about 4,000 vehicles to 8,000 by the end of 2026 and 20,000 by the end of 2027, after closing a $5 billion term loan and a $16 billion equity raise this year. Uber has committed to buying at least 35,000 Lucid vehicles, while its Rivian deal starts with 10,000 autonomous R2 SUVs, with rides expected to begin in 2028. Calacanis, who recently bought small stakes in Lucid, Rivian, WeRide (WRD) and Pony.ai (PONY), expects consolidation in the autonomous-driving sector within 24 months.
- Prediction: Oct. 21 Will Be a Huge Day for the Stock Market
The article predicts October 21 could be a pivotal day for the stock market, as Meta Platforms (META) becomes the first of the "Magnificent Seven" tech giants to report third-quarter earnings after the close. In its latest quarter, Meta's total revenue rose 28% to $60 billion, with ad revenue at $59 billion. Investors will be watching whether its capital spending, now about 35% of revenue, is translating into growth. Meta's report could hint at the earnings outlook for other tech giants and set the direction for the S&P 500 in the coming days, with the first trading session after the report on Thursday.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.